RE UPDATES7 Sep 2021 00:10
Jace, i believe you are correct re the manipulation.
Does anyone really think that trades of £15k warrants a drop of nearly 3% of the company's value? At that rate, then the market would value the entire company at just £495k. Note the spread of 22% Clearly designed to put the day traders off.
If you really want to see this in action, look no further than the share i previously mentioned would be good to get into. (eua) Continuous negative posts, dropping share price for ages, then the news comes. Up 140% on 5 days so far.
RE lack of news?
The issuing of RNS's costs the company money. Personally i would much prefer the BOD to spend that money on getting our product development advanced.
However, i do expect that we will shortly have news on the status of the development of the antibodies, and reagents we require for the ELISA test. Followed possibly by news that the successful manufacture of these protein complexes are to be licensed for use on other biosector's platforms.
News should then follow on regarding the test being produced in numbers sufficient to support a retrospective clinical study with patient samples.
By the end of the year, if not before, i fully expect that we will be in a position to submit at least an application for CE approval, and probably FDA too.
I further expect news later on the development of the companion diagnostic. This may or may not include further news on a further opportunity available to us by the re-purposing of currently shelved, but phase 2 approved drugs by other companies. (by re-purposing, i mean the different use of a drug, from it's intended manufacture. For example, Viagra was originally developed to treat Angina/high blood pressure).
Plenty of news to come, but as i said previously, this is a longer term investment, not a quick flip.
Neil